![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/BPLPHARMA.png)
Share the post "Bharat Parenterals ‘s Q3 2024-25 Latest News: Profit Falls by 316.21% Year-on-Year"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 20.8 % in the past year, substantial increase in net sales/revenue by 0.88 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 134.13 %. Marginal decrease of -29.93% in other income during this quarter. 🔹 Profit over the Year and quarter: Challenges in sustaining profitability for Bharat Parenterals Limited. Profit dropped by -316.21 % Year to Year, Bharat Parenterals Limited’s profitability dropped by -55.08 % Quarter to Quarter. 🔹 EPS over the Year and quarter: EPS declined by -255.04 % Year to Year. EPS decreased by -62.96 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 59.82 Cr | Rs. 71.63 Cr | Rs. 72.26 Cr | + 0.88 % | + 20.8 % |
| Expenses | Rs. 53.2 Cr | Rs. 79.3 Cr | Rs. 68.62 Cr | -13.47 % | + 28.98 % |
| Operating Profit | Rs. 6.62 Cr | Rs. -7.67 Cr | Rs. 3.64 Cr | + 147.46 % | -45.02 % |
| OPM % | 11.07 % | -10.71 % | 5.04 % | + 15.75 % | -6.03 % |
| Other Income | Rs. 1.26 Cr | Rs. 4.21 Cr | Rs. 2.95 Cr | -29.93 % | + 134.13 % |
| Interest | Rs. 0.58 Cr | Rs. 2.91 Cr | Rs. 3.33 Cr | + 14.43 % | + 474.14 % |
| Depreciation | Rs. 1.83 Cr | Rs. 9.01 Cr | Rs. 8.76 Cr | -2.77 % | + 378.69 % |
| Profit before tax | Rs. 5.47 Cr | Rs. -15.38 Cr | Rs. -5.5 Cr | + 64.24 % | -200.55 % |
| Tax % | 33.46 % | -13.91 % | -43.09 % | -29.18 % | -76.55 % |
| Net Profit | Rs. 3.64 Cr | Rs. -17.52 Cr | Rs. -7.87 Cr | + 55.08 % | -316.21 % |
| EPS in Rs | Rs. 6.45 | Rs. -27 | Rs. -10 | + 62.96 % | -255.04 % |
Today, we’re looking at Bharat Parenterals Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 20.8 %. However, it did see a marginal increase of 0.88 % from the previous quarter. Expenses decreased slightly by -13.47 % quarter-on-quarter, aligning with the annual rise of 28.98 %. Operating profit, while down -45.02 % compared to last year, faced a quarter-on-quarter increase of 147.46 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -6.03 %, but an expansion of 15.75 % sequentially. Other income fell by -29.93 % compared to the last quarter, despite an annual growth of 134.13 %. Interest expenses surged remarkably by 14.43 % from the previous quarter, yet the year-over-year increase remains at a moderate 474.14 %. Depreciation costs fell by -2.77 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 378.69 %. Profit before tax declined annually by -200.55 % but saw an increase from the preceding quarter by 64.24 %.
Tax expenses as a percentage of profits decreased slightly by -76.55 % compared to last year, with a more notable quarter-on-quarter decrease of -29.18 %. Net profit fell by -316.21 % year-on-year but experienced a 55.08 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -255.04 % but a quarterly rise of 62.96 %. In summary, Bharat Parenterals Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 59.82 Cr | Rs. 71.63 Cr | Rs. 72.26 Cr | + 0.88 % | + 20.8 % |
| Expenses | Rs. 53.2 Cr | Rs. 79.3 Cr | Rs. 68.62 Cr | -13.47 % | + 28.98 % |
| Operating Profit | Rs. 6.62 Cr | Rs. -7.67 Cr | Rs. 3.64 Cr | + 147.46 % | -45.02 % |
| Net Profit | Rs. 3.64 Cr | Rs. -17.52 Cr | Rs. -7.87 Cr | + 55.08 % | -316.21 % |
| EPS in Rs | Rs. 6.45 | Rs. -27 | Rs. -10 | + 62.96 % | -255.04 % |
In reviewing Bharat Parenterals Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 20.8 % year-on-year growth, however, there was a minor increase of 0.88 % from the previous quarter. Expenses rose by 28.98 % compared to the previous year, with a decrease of -13.47 % quarter-on-quarter. Operating Profit dropped by -45.02 % annually, and saw a 147.46 % increase from the last quarter.
Net Profit showed yearly decrease of -316.21 %, and experienced a 55.08 % increase from the previous quarter. Earnings Per Share (EPS) fell by -255.04 % annually, however rose by 62.96 % compared to the last quarter. In essence, while Bharat Parenterals Limited faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
 LIMITED logo1.jpg){kind=logo}
